Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Heidi Crayton (NPI 1669470720)

Field	Value
Entity Type	Individual
Organization	Heidi Crayton
Address	8320 Old Courthouse Rd
City	Vienna
State	VA
ZIP	22182
Taxonomy	Neurology Physician
NPI Enumerated	July 13, 2005

Payer Source	Total Paid
Medicare	$2.4M
Medicaid	$0

Key Findings

HEIDI CRAYTON is a Neurology Physician enumerated on 2005-07-13 (~21 years ago), indicating long-standing Medicare participation and an established billing history in the Vienna, VA market. The provider’s tenure suggests sustained operations over two decades, which supports continuity for specialty infusion services reported below.

This provider’s billing is effectively single-payer: Total Medicare revenue is $2.4M and there is no Medicaid billing on file. The absence of Medicaid activity means analyses of payer mix, access, and low-income patient volumes should treat Medicare as the operational driver for this profile.

Revenue is highly concentrated in a small number of infusion/biologic codes: the top 3 Medicare codes by revenue (J2323, J2350, J0517) account for 84.4% of this provider’s total Medicare revenue. Specifically, J2323 represents 42.1% of Medicare revenue, J2350 represents 32.0%, and J0517 represents 10.3%, signaling dependence on a handful of high-cost injectable therapies.

The code mix points to an infusion-centric specialty practice: J2323 (natalizumab) and J2350 (ocrelizumab) are high-cost monoclonal antibody infusions commonly used in multiple sclerosis and neuroimmunologic care, while J0517 (benralizumab) and J2357 (omalizumab) reflect additional biologic injectables. The presence of chemotherapy administration codes (96413, 96401, 96415, 96365) further indicates on-site infusion/administration capability rather than a predominant office E/M-only model.

Competitive standing is mixed across products: J2323 ranks #5 of 40 providers nationally (90th percentile), identifying this provider as a leading supplier of that specific drug within a relatively small national cohort. By contrast, J2350 ranks #32 of 105 (70th percentile) and J0517 ranks #46 of 200 (77th percentile), indicating solid but not dominant volume for those agents compared with national peers.

There are notable statistical outliers in utilization patterns that merit attention: J2930 (methylprednisolone injection) is labeled an "extreme outlier, far above typical national volume" at rank #31 of 2459 (99th percentile) despite contributing only $2.2K in revenue, and 96413 (chemotherapy infusion) is "notably above typical national volume" at the 94th percentile with $70.2K in revenue. These flags suggest atypical intensity for selected low-revenue codes relative to national peers.

E/M services are a small fraction of revenue relative to infusion codes: 99215 accounts for $30.2K (1.2% of Medicare revenue) and 99205 is only $2.4K (0.1%), implying the practice model prioritizes infused biologics and administered therapies over high-volume office evaluation and management encounters. Analysts should therefore focus on infusion throughput, drug procurement, and reimbursement dynamics rather than traditional outpatient visit volume.

Operational and contracting implications follow from the concentration in high-cost biologics: reliance on J2323 and J2350 for the bulk of Medicare revenue creates exposure to drug-specific reimbursement changes and a potential negotiating lever with payers given high per-provider ranks for some codes. Given the long NPI tenure and the infusion-heavy code mix, contracting and network strategy should emphasize infusion capacity, drug storage/handling, and billing accuracy for injectable biologics.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

11 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2323	Injection, natalizumab, 1 mg	53,700	$20	$1M
J2350	Injection, ocrelizumab, 1 mg	18,000	$40	$774K
J0517	Injection, benralizumab, 1 mg	1,890	$130	$249.5K
J2357	Injection, omalizumab, 5 mg	8,000	$30	$239.8K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	580	$120	$70.2K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	200	$150	$30.2K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	320	$70	$21.7K
96415	In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…	260	$30	$6.4K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	80	$60	$4.7K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	10	$170	$2.4K

Showing 1–10 of 11

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 11 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Heidi Crayton — 1 of 11 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

11 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2350	3	10	25,200	$40	$1.8M
J2323	1	10	53,700	$20	$1M
J0517	5	20	1,200	$130	$213K
J2357	12	40	5,630	$30	$212.4K
96413	19	230	250	$100	$28.5K
96401	23	180	110	$60	$11.5K
99215	351	4,030	40	$120	$9.5K
96365	121	220	100	$50	$6.5K
99205	1,296	1,620	30	$150	$5.7K
96415	11	170	100	$20	$2.7K

Showing 1–10 of 11

Related Providers

Other providers that share a Tax Identification Number (TIN) with Heidi Crayton, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Susan Stuart	DC	Family Nurse Practitioner	$27.8K	$0

Nearby Providers

Other providers in the same ZIP code as Heidi Crayton, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mps Healthcare Inc	VA	Home Health Agency	$0	$81.3M
Ata&ana LLC	VA	Personal Care Attendant	$0	$50.5M
Advanced 4 Healthcare Inc	VA	Home Health Agency	$0	$33.2M
Careplus Home Health Services	VA	Home Health Agency	$0	$26.8M
Home Link Care, LLC	VA	Home Health Agency	$0	$24.9M
Passion Home Health Solutions LLC	VA	Home Health Agency	$0	$15.4M
Pediatric Therapy Studio	VA	Behavior Analyst	$0	$7.7M
Dal Chun	VA	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
Jung Woo	VA	Retina Specialist (Ophthalmology) Physician	$1.8M	$2.1K
Mahnaz Momeni	VA	Rheumatology Physician	$753.9K	$0

Heidi Crayton — Billing Profile & Reimbursement Data

Sign up for Heidi Crayton — Billing Profile & Reimbursement Data policy alerts

Heidi Crayton — Billing Profile & Reimbursement Data

Sign up for Heidi Crayton — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References